METFORMIN PLUS MYOINOSITOL VERSUS METFORMIN IN POLYCYSTIC OVARIAN SYNDROME WOMEN UNDERGOING OVULATIONIN DUCTION WITH LETROZOLE

Document Type : Preliminary preprint short reports of original research

Authors

1 Department of Obstetrics and Gynecology, Faculty of Medicine- Alexandria University.

2 Department of Obstetrics and Gynecology, Faculty of Medicine

3 Department of Obstetrics and Gynecology, Faculty of Medicine, University of Alexandria

Abstract

PCOS is a syndromic disease presents in women in a myriad of ways, a spectrum of clinical signs and symptoms. Clinical or biochemical hyperandrogenism, oligo- an ovulation and polycystic morphology are the generally accepted diagnostic criteria.
Those women have an increased risk of metabolic and reproductive disorders, such as type 2 diabetes mellitus, obesity and dyslipidemia. Oligo/an ovulatory women without clinical or bio- chemical evidence of hyperandrogenism tend to be the least affected by the sequela of PCOS, so the accurately diagnosing women may assist clinicians in predicting life-long risks and interventions to patients on a more individualized basis.
Assessing the effect of combined metformin and myo-inositol as compared to metformin alone in terms of ovarian response of infertile PCOS women undergoing ovulation induction cycles is the main scope of this study.

AIM OF THE WORK:
The aim of this work was to assess the effect of combined metformin and myo-inositol as compared to metformin alone in terms of ovarian response and improvement in insulin resistance parameters in infertile PCOS women undergoing ovulation induction cycles.

Keywords

ALEXMED ePosters
Volume 6, Issue 4
September 2024
Pages 14-15

Files

Share

How to cite

Statistics